HealthEquity, Inc. (HQY) Income Statement Analysis

See more : Thoresen Thai Agencies Public Company Limited (TTA-R.BK) Income Statement Analysis – Financial Results

Complete financial analysis of HealthEquity, Inc. (HQY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HealthEquity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.

You may be interested

HealthEquity, Inc. (HQY)

Industry: Medical - Healthcare Information Services

Sector: Healthcare

Website: https://www.healthequity.com

About HealthEquity, Inc.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	999.59M	861.75M	756.56M	733.57M	531.99M	287.24M	229.53M	178.37M	126.79M	87.86M	62.02M	46.09M
Cost of Revenue	376.95M	371.66M	332.85M	318.24M	206.08M	106.05M	94.61M	72.02M	54.19M	39.88M	29.21M	21.97M
Gross Profit	622.64M	490.09M	423.71M	415.33M	325.91M	181.19M	134.92M	106.36M	72.60M	47.97M	32.80M	24.12M
Gross Profit Ratio	62.29%	56.87%	56.00%	56.62%	61.26%	63.08%	58.78%	59.63%	57.26%	54.60%	52.89%	52.33%
Research & Development	218.81M	193.38M	157.36M	124.81M	77.58M	35.06M	27.39M	22.38M	16.83M	10.50M	7.14M	4.23M
General & Administrative	103.66M	95.63M	84.38M	84.49M	60.56M	33.04M	25.11M	20.15M	14.11M	8.34M	3.90M	3.37M
Selling & Marketing	79.27M	68.85M	58.61M	49.96M	43.95M	29.50M	23.14M	18.32M	13.30M	10.62M	8.60M	7.80M
SG&A	182.93M	164.48M	142.98M	134.46M	104.51M	62.54M	48.25M	38.47M	27.42M	18.96M	12.50M	11.16M
Other Expenses	0.00	94.59M	82.79M	76.06M	34.70M	-1.85M	-2.23M	-1.09M	-589.00K	-374.00K	-129.00K	-147.00K
Operating Expenses	401.74M	452.44M	383.14M	335.33M	216.79M	103.52M	80.50M	65.14M	46.46M	31.10M	21.28M	17.03M
Cost & Expenses	871.45M	824.10M	715.99M	653.57M	422.88M	209.57M	175.11M	137.16M	100.64M	70.98M	50.49M	39.00M
Interest Income	12.14M	1.76M	1.50M	1.05M	5.91M	1.68M	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	55.46M	48.42M	36.57M	34.88M	24.77M	0.00	0.00	0.00	0.00	0.00	44.00K	326.00K
Depreciation & Amortization	153.08M	161.20M	137.19M	115.90M	55.35M	18.19M	15.95M	13.19M	8.60M	1.64M	4.27M	3.37M
EBITDA	282.42M	171.53M	102.97M	154.93M	123.28M	94.00M	68.14M	54.40M	34.74M	22.76M	15.79M	10.19M
EBITDA Ratio	28.25%	23.22%	22.71%	27.15%	29.21%	33.37%	30.66%	30.50%	27.40%	20.64%	25.26%	22.37%
Operating Income	128.13M	38.92M	34.64M	83.28M	77.01M	77.67M	54.42M	41.21M	26.14M	16.87M	11.52M	7.09M
Operating Income Ratio	12.82%	4.52%	4.58%	11.35%	14.48%	27.04%	23.71%	23.10%	20.62%	19.21%	18.58%	15.39%
Total Other Income/Expenses	-53.09M	-47.15M	-42.50M	-29.87M	-33.85M	-1.85M	-2.23M	-1.09M	-589.00K	-1.11M	-6.15M	-590.00K
Income Before Tax	75.04M	-38.10M	-66.74M	4.14M	43.16M	75.82M	52.19M	40.12M	25.55M	15.76M	5.37M	6.50M
Income Before Tax Ratio	7.51%	-4.42%	-8.82%	0.56%	8.11%	26.40%	22.74%	22.49%	20.16%	17.94%	8.67%	14.11%
Income Tax Expense	19.33M	-11.95M	-22.45M	-4.69M	3.49M	1.92M	4.83M	13.74M	8.94M	5.60M	4.14M	-4.67M
Net Income	55.71M	-26.14M	-44.29M	8.83M	39.66M	73.90M	47.36M	26.38M	16.61M	10.17M	1.23M	11.17M
Net Income Ratio	5.57%	-3.03%	-5.85%	1.20%	7.46%	25.73%	20.63%	14.79%	13.10%	11.57%	1.99%	24.23%
EPS	0.65	-0.31	-0.53	0.12	0.59	1.20	0.79	0.45	0.29	0.39	-1.26	0.51
EPS Diluted	0.64	-0.31	-0.53	0.12	0.58	1.17	0.77	0.44	0.28	0.21	-1.26	0.21
Weighted Avg Shares Out	85.56M	84.44M	83.13M	74.24M	67.03M	61.84M	60.30M	58.62M	56.72M	31.18M	5.65M	7.76M
Weighted Avg Shares Out (Dil)	86.96M	84.44M	83.13M	75.68M	68.45M	63.37M	61.85M	59.89M	58.86M	51.86M	5.65M	45.85M

Unlocking Q3 Potential of HealthEquity (HQY): Exploring Wall Street Estimates for Key Metrics

December 6, 2024zacks.com

Beyond analysts' top -and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.

HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators

December 3, 2024globenewswire.com

SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and...

HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?

November 25, 2024zacks.com

HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Investment Committee Moves: EPAM, Paycom, Blackstone, Healthequity, Booz Allen, Leidos, and Vertiv

November 21, 2024youtube.com

Karen Firestone and Steve Weiss join CNBC's 'Halftime Report' to detail their latest portfolio moves.

HealthEquity Gains 54.6% YTD: What's Driving the Stock?

November 20, 2024zacks.com

HQY's sustained strength in HSAs raises optimism about the stock.

HealthEquity: High Marks For Recent Profit Growth

November 20, 2024seekingalpha.com

HealthEquity's future growth relies heavily on capital reinvestment due to the asset-light nature of the business. High multiples of capital are necessary to ensure each $1 of retained and reinvested earnings is valued highly by the market. The core asset...